CD19 and leukemia: In this study, we demonstrated that NK cells pre-activated with IL-12/-15/-18 prior to transduction of CD19 CAR resulted in a more activated, non-exhausted and memory-like phenotype associated with increased IFN-γ production, degranulation, and specific killing against CD19+ leukemia and lymphoma cells.